Recurrent Pancreatic Carcinoma Completed Phase 0 Trials for Irinotecan (DB00762)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02896907Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryTreatment